GR3035768T3 - Substituted Phenylimidazolidins, process for their preparation, their use as medicaments and their pharmaceutical compositions containing them. - Google Patents
Substituted Phenylimidazolidins, process for their preparation, their use as medicaments and their pharmaceutical compositions containing them.Info
- Publication number
- GR3035768T3 GR3035768T3 GR20010400616T GR20010400616T GR3035768T3 GR 3035768 T3 GR3035768 T3 GR 3035768T3 GR 20010400616 T GR20010400616 T GR 20010400616T GR 20010400616 T GR20010400616 T GR 20010400616T GR 3035768 T3 GR3035768 T3 GR 3035768T3
- Authority
- GR
- Greece
- Prior art keywords
- medicaments
- substituted
- preparation
- halogen
- phenylimidazolidins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/86—Oxygen and sulfur atoms, e.g. thiohydantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/88—Nitrogen atoms, e.g. allantoin
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR929208431A FR2693461B1 (fr) | 1992-07-08 | 1992-07-08 | Nouvelles phénylimidazolidines substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant. |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3035768T3 true GR3035768T3 (en) | 2001-07-31 |
Family
ID=9431679
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR20010400616T GR3035768T3 (en) | 1992-07-08 | 2001-04-20 | Substituted Phenylimidazolidins, process for their preparation, their use as medicaments and their pharmaceutical compositions containing them. |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0580459B1 (el) |
JP (1) | JP3845455B2 (el) |
KR (1) | KR100294383B1 (el) |
CN (1) | CN1044234C (el) |
AT (1) | ATE200077T1 (el) |
AU (1) | AU670942B2 (el) |
CA (1) | CA2097248A1 (el) |
DE (1) | DE69330058T2 (el) |
DK (1) | DK0580459T3 (el) |
ES (1) | ES2155067T3 (el) |
FR (1) | FR2693461B1 (el) |
GR (1) | GR3035768T3 (el) |
HU (1) | HUT64527A (el) |
PT (1) | PT580459E (el) |
RU (1) | RU2116298C1 (el) |
UA (1) | UA34428C2 (el) |
ZA (1) | ZA933786B (el) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2724169B1 (fr) * | 1994-09-06 | 1997-01-03 | Roussel Uclaf | Nouvelles phenylimidazolidines eventuellement substituees, leur procede et des intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant |
TW521073B (en) * | 1994-01-05 | 2003-02-21 | Hoechst Marion Roussel Inc | New optionally substituted phenylimidazolidines, their preparation process, their use as anti-androgenic agent and the pharmaceutical compositions containing them |
FR2715402B1 (fr) * | 1994-01-05 | 1996-10-04 | Roussel Uclaf | Nouvelles phénylimidazolines éventuellement substituées, leur procédé et des intermédiaires de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant. |
AU726572B2 (en) * | 1994-02-16 | 2000-11-09 | Aventis Pharma S.A. | Cosmetics or pharmaceutical compositions consisting of liposomes |
FR2716110B1 (fr) | 1994-02-16 | 1996-04-05 | Roussel Uclaf | Compositions cosmétiques ou pharmaceutiques comprenant des liposomes. |
US5656651A (en) * | 1995-06-16 | 1997-08-12 | Biophysica Inc. | Androgenic directed compositions |
FR2741342B1 (fr) * | 1995-11-22 | 1998-02-06 | Roussel Uclaf | Nouvelles phenylimidazolidines fluorees ou hydroxylees, procede, intermediaires de preparation, application comme medicaments, nouvelle utilisation et compositions pharmaceutiques |
FR2742749B1 (fr) | 1995-12-22 | 1998-02-06 | Roussel Uclaf | Nouvelles phenylimidazolidines comportant notamment un radical nitrooxy ou carbonyloxy, procede et intermediaires de preparation, application comme medicaments, nouvelles utilisations et compositions pharmaceutiques |
WO2000024366A1 (de) * | 1998-10-23 | 2000-05-04 | Aventis Pharma Deutschland Gmbh | Zubereitungen zur topischen applikation von antiandrogen wirksamen substanzen |
JP4621335B2 (ja) | 2000-06-28 | 2011-01-26 | セイコーエプソン株式会社 | 情報端末用プリンタユニット |
AU2002360932A1 (en) * | 2001-11-23 | 2003-06-10 | Schering Aktiengesellschaft | Piperazine derivatives destabilising androgen receptors |
US6861432B2 (en) | 2001-11-23 | 2005-03-01 | Schering Aktiengesellschaft | Piperazine derivatives that destabilize androgen receptors |
DE10218963A1 (de) * | 2002-04-27 | 2003-11-20 | Aventis Pharma Gmbh | Zubereitungen zur topischen Applikation von antiandrogen wirksamen Substanzen |
US20060025589A1 (en) * | 2002-10-01 | 2006-02-02 | Jean Binet | 2-Thiohydantoine derivative compounds and use thereof for the treatment of diabetes |
FR2845383B1 (fr) * | 2002-10-04 | 2004-12-31 | Fournier Lab Sa | Composes derives de la 2-thiohydantoine et leur utilisation en therapeutique |
DE10322108B4 (de) * | 2003-05-09 | 2008-12-11 | Bayer Schering Pharma Aktiengesellschaft | Antiandrogene Pyrrolidine mit tumorhemmender Wirksamkeit |
WO2004111012A1 (ja) * | 2003-06-12 | 2004-12-23 | Chugai Seiyaku Kabushiki Kaisha | イミダゾリジン誘導体 |
ATE502298T1 (de) | 2003-12-19 | 2011-04-15 | Univ California | Verfahren und materialien zur beurteilung von prostatakrebstherapien |
AU2005232526B2 (en) | 2004-02-24 | 2011-06-23 | The Regents Of The University Of California | Methods and materials for assessing prostate cancer therapies and compounds |
EP1621535A1 (en) * | 2004-07-27 | 2006-02-01 | Aventis Pharma S.A. | Substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
TW200612920A (en) * | 2004-08-03 | 2006-05-01 | Chugai Pharmaceutical Co Ltd | Novel imidazolidine derivatives |
TW200621723A (en) * | 2004-09-09 | 2006-07-01 | Chugai Pharmaceutical Co Ltd | Novel imidazolidine derivative and use thereof |
US7709517B2 (en) | 2005-05-13 | 2010-05-04 | The Regents Of The University Of California | Diarylhydantoin compounds |
AU2013203255C1 (en) * | 2005-05-13 | 2017-01-19 | The Regents Of The University Of California | Diarylthiohydantoin compounds |
KR101169832B1 (ko) * | 2005-05-13 | 2012-07-30 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | 디아릴히단토인 화합물 |
SI1891038T1 (sl) * | 2005-05-13 | 2009-04-30 | Lilly Co Eli | Substituirani n-arilpirolodini kot selektivni modulatorji androgenskega receptorja |
US7709516B2 (en) * | 2005-06-17 | 2010-05-04 | Endorecherche, Inc. | Helix 12 directed non-steroidal antiandrogens |
CN101032483B (zh) * | 2006-03-09 | 2011-05-04 | 陈德桂 | 调节雄激素受体活性的乙内酰脲衍生物及其应用 |
EP3412290B1 (en) | 2006-03-27 | 2021-03-03 | The Regents of The University of California | Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases |
CN101460467B (zh) * | 2006-03-29 | 2012-09-19 | 加利福尼亚大学董事会 | 二芳基硫代乙内酰脲化合物 |
US9284345B2 (en) | 2007-04-12 | 2016-03-15 | Endorecherche, Inc. | 17alpha-substituted steroids as systemic antiandrogens and selective androgen receptor modulators |
JP5535925B2 (ja) | 2007-10-26 | 2014-07-02 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | アンドロゲン受容体調節物質としてのジアリールヒダントイン化合物 |
WO2009097996A1 (de) * | 2008-02-07 | 2009-08-13 | Sanofi-Aventis | Verwendung von substituierten phenylimidazolidinen zur herstellung von arzneimitteln zur behandlung des metabolischen syndroms |
EP2242747A1 (de) * | 2008-02-07 | 2010-10-27 | Sanofi-Aventis | Substituierte imidazolidin-2,4-dione, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und ihre verwendung |
US8268872B2 (en) | 2008-02-22 | 2012-09-18 | Radius Health, Inc. | Selective androgen receptor modulators |
ES2488990T3 (es) | 2008-02-22 | 2014-09-01 | Radius Health, Inc. | Moduladores selectivos del receptor de andrógenos |
CA2725680A1 (en) | 2008-05-30 | 2009-12-03 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
WO2010069519A1 (en) | 2008-12-18 | 2010-06-24 | Merz Pharma Gmbh & Co. Kgaa | Topical compositions comprising at least one active ingredient poorly soluble in water and biopolymers such as hyaluronic acid with a pka-value between 5-7 |
SG172986A1 (en) | 2009-02-10 | 2011-08-29 | Astrazeneca Ab | Triazolo [4,3-b] pyridazine derivatives and their uses for prostate cancer |
FR2944524B1 (fr) * | 2009-04-17 | 2012-11-30 | Ipsen Pharma Sas | Derives d'imidazolidine-2,4-dione et leur utilisation comme medicament |
TW201111378A (en) | 2009-09-11 | 2011-04-01 | Bayer Schering Pharma Ag | Substituted (heteroarylmethyl) thiohydantoins |
FR2954316B1 (fr) | 2009-12-23 | 2014-01-03 | Galderma Res & Dev | Nouveaux derives phenoliques, et leur utilisation pharmaceutique ou cosmetique |
FR2954315B1 (fr) | 2009-12-23 | 2012-02-24 | Galderma Res & Dev | Nouveaux derives phenoliques, et leur utilisation pharmaceutique ou cosmetique |
FR2954317B1 (fr) | 2009-12-23 | 2012-01-27 | Galderma Res & Dev | Nouveaux derives phenoliques, et leur utilisation pharmaceutique ou cosmetique |
EP2531029B1 (en) | 2010-02-04 | 2016-10-19 | Radius Health, Inc. | Selective androgen receptor modulators |
SI3124481T1 (en) | 2010-02-16 | 2018-06-29 | Aragon Pharmaceuticals, Inc. | Androgen receptor modulators and their use |
BR112012021406B1 (pt) * | 2010-02-24 | 2021-08-10 | Medivation Prostate Therapeutics Llc | Processos para a síntese dos compostos de diariltioidantoína e diarilidantoína |
WO2011143469A1 (en) | 2010-05-12 | 2011-11-17 | Radius Health,Inc | Therapeutic regimens |
US8642632B2 (en) | 2010-07-02 | 2014-02-04 | Radius Health, Inc. | Selective androgen receptor modulators |
WO2012047617A1 (en) | 2010-09-28 | 2012-04-12 | Radius Health, Inc. | Selective androgen receptor modulators |
MY180834A (en) | 2012-09-26 | 2020-12-10 | Aragon Pharmaceuticals Inc | Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer |
JOP20200097A1 (ar) | 2013-01-15 | 2017-06-16 | Aragon Pharmaceuticals Inc | معدل مستقبل أندروجين واستخداماته |
US9682960B2 (en) | 2013-12-19 | 2017-06-20 | Endorecherche, Inc. | Non-steroidal antiandrogens and selective androgen receptor modulators with a pyridyl moiety |
EP3834824A1 (en) | 2014-03-28 | 2021-06-16 | Duke University | Method of treating cancer using selective estrogen receptor modulators |
US9421264B2 (en) | 2014-03-28 | 2016-08-23 | Duke University | Method of treating cancer using selective estrogen receptor modulators |
CN103965112A (zh) * | 2014-05-13 | 2014-08-06 | 上海孚一生物科技有限公司 | 一种具有抗雄激素活性的化合物、制备方法及其应用 |
TWI726969B (zh) | 2016-01-11 | 2021-05-11 | 比利時商健生藥品公司 | 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物 |
WO2017223115A1 (en) | 2016-06-22 | 2017-12-28 | Radius Health, Inc. | Ar+ breast cancer treatment methods |
JP7481115B2 (ja) | 2017-01-05 | 2024-05-10 | ラジウス ファーマシューティカルズ,インコーポレイテッド | Rad1901-2hclの多形性形態 |
AU2018351714A1 (en) | 2017-10-16 | 2020-04-30 | Aragon Pharmaceuticals, Inc. | Anti-androgens for the treatment of non-metastatic castration-resistant prostate cancer |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4916937B1 (el) * | 1970-01-21 | 1974-04-25 | ||
US3823240A (en) * | 1970-10-06 | 1974-07-09 | Rhone Poulenc Sa | Fungicidal hydantoin derivatives |
US3923994A (en) * | 1973-07-13 | 1975-12-02 | Smithkline Corp | Anti-arthritic compositions comprising a 3-aryl 2-thiohydantoin and methods of producing anti-arthritic acitvity |
FR2329276A1 (fr) * | 1975-10-29 | 1977-05-27 | Roussel Uclaf | Nouvelles imidazolidines substituees, procede de preparation, application comme medicament et compositions les renfermant |
MC1220A1 (fr) * | 1977-10-28 | 1979-07-20 | Hoffmann La Roche | Nouveaux derives d'imidazolidine |
DE2933917A1 (de) * | 1979-08-22 | 1981-03-26 | Basf Ag, 67063 Ludwigshafen | 5-imino-imidazolidin-2-one und diese enthaltende herbizide. |
US4753957A (en) * | 1981-09-28 | 1988-06-28 | Rohm And Haas Company | Substituted 2,4-imidazolidinediones and fungicidal compositions |
EP0091596B1 (de) * | 1982-04-08 | 1991-09-11 | Shell Internationale Researchmaatschappij B.V. | Neue Hydantoine, ihre Herstellung und Verwendung |
US4473393A (en) * | 1982-08-06 | 1984-09-25 | Buffalo Color Corporation | Pesticidal thiohydantoin compositions |
FR2656302B1 (fr) * | 1989-12-22 | 1992-05-07 | Roussel Uclaf | Nouveau procede de preparation de l'anandron et derives de l'anandron. |
FR2671348B1 (fr) * | 1991-01-09 | 1993-03-26 | Roussel Uclaf | Nouvelles phenylimidazolidines, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant. |
-
1992
- 1992-07-08 FR FR929208431A patent/FR2693461B1/fr not_active Expired - Fee Related
-
1993
- 1993-05-28 CA CA002097248A patent/CA2097248A1/fr not_active Abandoned
- 1993-05-28 EP EP93401361A patent/EP0580459B1/fr not_active Expired - Lifetime
- 1993-05-28 DE DE69330058T patent/DE69330058T2/de not_active Expired - Fee Related
- 1993-05-28 DK DK93401361T patent/DK0580459T3/da active
- 1993-05-28 ES ES93401361T patent/ES2155067T3/es not_active Expired - Lifetime
- 1993-05-28 PT PT93401361T patent/PT580459E/pt unknown
- 1993-05-28 RU RU93005350A patent/RU2116298C1/ru not_active IP Right Cessation
- 1993-05-28 JP JP14837193A patent/JP3845455B2/ja not_active Expired - Fee Related
- 1993-05-28 AT AT93401361T patent/ATE200077T1/de not_active IP Right Cessation
- 1993-05-28 ZA ZA933786A patent/ZA933786B/xx unknown
- 1993-05-28 HU HU9301585A patent/HUT64527A/hu unknown
- 1993-05-28 CN CN93106567A patent/CN1044234C/zh not_active Expired - Fee Related
- 1993-05-29 KR KR1019930009431A patent/KR100294383B1/ko not_active IP Right Cessation
- 1993-05-31 AU AU39876/93A patent/AU670942B2/en not_active Ceased
- 1993-06-18 UA UA93003085A patent/UA34428C2/uk unknown
-
2001
- 2001-04-20 GR GR20010400616T patent/GR3035768T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
FR2693461B1 (fr) | 1994-09-02 |
JPH0673017A (ja) | 1994-03-15 |
EP0580459A1 (fr) | 1994-01-26 |
RU2116298C1 (ru) | 1998-07-27 |
HU9301585D0 (en) | 1993-09-28 |
AU670942B2 (en) | 1996-08-08 |
UA34428C2 (uk) | 2001-03-15 |
KR940005582A (ko) | 1994-03-21 |
ATE200077T1 (de) | 2001-04-15 |
EP0580459B1 (fr) | 2001-03-28 |
PT580459E (pt) | 2001-07-31 |
ZA933786B (en) | 1994-05-30 |
CA2097248A1 (fr) | 1994-01-09 |
AU3987693A (en) | 1994-01-13 |
DK0580459T3 (da) | 2001-06-11 |
CN1044234C (zh) | 1999-07-21 |
KR100294383B1 (ko) | 2001-09-17 |
ES2155067T3 (es) | 2001-05-01 |
JP3845455B2 (ja) | 2006-11-15 |
CN1081182A (zh) | 1994-01-26 |
DE69330058T2 (de) | 2001-09-06 |
FR2693461A1 (fr) | 1994-01-14 |
DE69330058D1 (de) | 2001-05-03 |
HUT64527A (en) | 1994-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR3035768T3 (en) | Substituted Phenylimidazolidins, process for their preparation, their use as medicaments and their pharmaceutical compositions containing them. | |
ZA9290B (en) | Phenylimidazolidines,process for their preparation,their use as medicaments and pharmaceutical compositions containing them | |
FI913478A0 (fi) | Diazinderivat. | |
IL110031A0 (en) | Phenyl heterocycles, their manufacture and pharmaceutical compositions containing them | |
GR3017996T3 (en) | 17-g(b)-SUBSTITUTED-4-AZA-5-g(a)-ANDROSTAN-3-ONE DERIVATIVES AND PROCESS FOR THEIR PREPARATION. | |
IL114537A (en) | Sulfonamide derivatives of azolones their preparation and pharmaceutical compositions containing them | |
HU900671D0 (en) | Process for preparation of heterociclyc compounds containing fused benzene-rings and nitrogen atom | |
ZA200110540B (en) | Novel diphenyl-piperidine derivate. | |
HU9303680D0 (en) | Inhibitors of hiv protease useful for the treatment of aids | |
DE3462250D1 (en) | Thioethers, process for their preparation and medicines containing these compounds | |
GB0104050D0 (en) | Chemical compounds | |
ZA984114B (en) | Substituted heterocyclic compounds a process for the preparation thereof and pharmaceutical compositions containing them | |
IL113254A0 (en) | Substituted azolone derivatives their preparation and pharmaceutical compositions containing them | |
ZA979338B (en) | Peptide compounds. | |
IT1223395B (it) | Composti ad attivita' cardiovascolare | |
ES8604843A1 (es) | Un metodo para la preparacion de un derivado de acetileno | |
GR3033175T3 (en) | Trifluoromethylsulfonylphenyl or trifluoromethylsulfinylphenyl group containing 2-cyano-3-hydroxy-propenamide derivatives, process for their preparation, their use as medicaments and pharmaceutical compositions containing them | |
JO1648B1 (en) | Nitrogen compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ML | Lapse due to non-payment of fees |